Effect of vitamin D on MS activity by disease-modifying therapy class

OBJECTIVE: To determine whether vitamin D status predicts disease activity in patients with multiple sclerosis (MS) taking interferon-β (IFN), glatiramer acetate (GA), and fingolimod (FTY). METHODS: Participants (n = 324) with relapsing-remitting MS on IFN (96), GA (151), or FTY (77) were identified...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotstein, Dalia L., Healy, Brian C., Malik, Muhammad T., Carruthers, Robert L., Musallam, Alexander J., Kivisakk, Pia, Weiner, Howard L., Glanz, Bonnie, Chitnis, Tanuja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630683/
https://www.ncbi.nlm.nih.gov/pubmed/26568968
http://dx.doi.org/10.1212/NXI.0000000000000167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630683/
https://www.ncbi.nlm.nih.gov/pubmed/26568968
http://dx.doi.org/10.1212/NXI.0000000000000167

Ejemplares similares